#USA #Columbus #Akita Biosciences #Profi Nasal Spray #Flu Lab

Akita Biosciences Partners with Flu Lab for Nasal Spray Study

Akita Biosciences, Inc., a pioneering company in consumer health solutions, has recently announced an exciting partnership with Flu Lab to evaluate its innovative product, Profi Nasal Spray, among healthcare workers in the U.S. This initiative stems from a grant aimed at assessing the feasibility, acceptability, and safety of using this drug-free nasal hygiene formulation in challenging healthcare settings.

The Need for Innovative Solutions

Healthcare professionals are routinely exposed to airborne particulate matter, which can carry various contaminants that pose health risks. Although traditional protective measures, such as masks and vaccines, are critical, there remains an evident demand for additional tools that can easily integrate into daily routines. The Profi Nasal Spray is engineered to provide an advanced, drug-free solution for cleansing nasal passages of airborne pollutants, thereby enhancing nasal hygiene without the use of pharmaceuticals.

Developed with a novel technology from researchers at Harvard Medical School, the Profi Nasal Spray forms a gel-like barrier within the nasal cavities. This unique formulation not only helps block but also clears airborne irritants, providing an essential layer of protection to healthcare workers dedicated to patient care.

Collaborative Research Efforts

The pilot study, backed by Flu Lab, will involve collaboration with NYC Health + Hospitals, the largest public healthcare system in the U.S. Over an eight-week period, healthcare workers will participate in a user adherence trial to gauge the daily usability and safety of the Profi Nasal Spray. This research is a significant step towards gathering real-world insights into the product's practicality in frontline healthcare settings, which will ultimately inform future strategies in respiratory health management.

Co-founder and CEO of Akita Biosciences, Alex Revelos, expressed optimism regarding the research. He acknowledged the challenges faced by healthcare workers, particularly those engaged in direct patient interactions. "By understanding how this nasal spray can fit into their routines, we hope to provide a complementary tool that enhances their safety," he noted.

Akita Biosciences: Innovation at the Forefront

Being named one of Fast Company's World's Most Innovative Companies in 2025, Akita Biosciences is on the cutting edge of health and wellness technology. Their products, including the Profi Nasal Spray, emphasize a shift from conventional health supplements, focusing specifically on the nasal pathways—an entry point for airborne germs and allergens. Through advanced formulation and a commitment to scientific excellence, Akita aims to redefine health practices in an increasingly airborne world.

To find more about their offerings, visit Akita Biosciences and Profi Spray.

This partnership with Flu Lab exemplifies the company’s focus on innovative health solutions and its dedication to supporting the well-being of those who serve in the healthcare field.

Conclusion

As the study progresses, it may offer valuable data that not only shapes the trajectory of clear nasal hygiene practices but also enhances the overall health and safety of healthcare workers across the country. Akita Biosciences is paving the way for safer healthcare environments with forward-thinking products like Profi Nasal Spray, setting new benchmarks for personal health management.

For inquiries, media contact Alex Revelos at (614) 285-4781 or via email at [email protected]